Basics Dyne Therapeutics, Inc. IPO Date: September 17, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.17B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.27% Avg Daily Range (30 D): $0.33 | 3.05% Avg Daily Range (90 D): $0.39 | 3.81% Institutional Daily Volume Avg Daily Volume: .67M Avg Daily Volume (30 D): 2.65M Avg Daily Volume (90 D): 2.26M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 100 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 1,731 Avg Inst. Trade: $2.62M Avg Inst. Trade (30 D): $2.72M Avg Inst. Trade (90 D): $2.38M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.09M Avg Closing Trade (30 D): $3.75M Avg Closing Trade (90 D): $3.72M Avg Closing Volume: 207.92K     News Jul 14, 2025 @ 2:00 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp Jul 1, 2025 @ 1:45 AM Dyne Therapeutics Announces Pricing of $200.0 Mill... Source: Dyne Therapeutics, Inc. Jun 24, 2025 @ 7:43 AM Dyne Therapeutics Investigated for Securities Frau... Source: Prnewswire Mar 16, 2025 @ 11:00 PM Dyne Therapeutics Announces New Long-Term Clinical... Source: N/A Jun 24, 2024 @ 11:30 AM Dyne Therapeutics Presents New Preclinical Data De... Source: Dyne Therapeutics, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.59 $-1.05 $-.88 Diluted EPS $-3.59 $-1.05 $-.88 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -367.13M $ -115.36M $ -89.54M Operating Income / Loss $ -397.1M $ -122.37M $ -97.11M Cost of Revenue $ $ $ Net Cash Flow $ 200.24M $ 36.81M $ -96.71M PE Ratio